These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37262387)

  • 1. Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist.
    Udompholkul P; Garza-Granados A; Alboreggia G; Baggio C; McGuire J; Pegan SD; Pellecchia M
    J Med Chem; 2023 Jun; 66(12):8159-8169. PubMed ID: 37262387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy.
    Baggio C; Udompholkul P; Gambini L; Salem AF; Jossart J; Perry JJP; Pellecchia M
    J Med Chem; 2019 Oct; 62(20):9188-9200. PubMed ID: 31550155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach.
    Baggio C; Gambini L; Udompholkul P; Salem AF; Aronson A; Dona A; Troadec E; Pichiorri F; Pellecchia M
    J Med Chem; 2018 Jul; 61(14):6350-6363. PubMed ID: 29940121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysine Covalent Antagonists of Melanoma Inhibitors of Apoptosis Protein.
    Udompholkul P; Baggio C; Gambini L; Alboreggia G; Pellecchia M
    J Med Chem; 2021 Nov; 64(21):16147-16158. PubMed ID: 34705456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic.
    Cossu F; Milani M; Vachette P; Malvezzi F; Grassi S; Lecis D; Delia D; Drago C; Seneci P; Bolognesi M; Mastrangelo E
    PLoS One; 2012; 7(11):e49527. PubMed ID: 23166698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues.
    Gambini L; Baggio C; Udompholkul P; Jossart J; Salem AF; Perry JJP; Pellecchia M
    J Med Chem; 2019 Jun; 62(11):5616-5627. PubMed ID: 31095386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability and Cell Permeability of Sulfonyl Fluorides in the Design of Lys-Covalent Antagonists of Protein-Protein Interactions.
    Gambini L; Udompholkul P; Salem AF; Baggio C; Pellecchia M
    ChemMedChem; 2020 Nov; 15(22):2176-2184. PubMed ID: 32790900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
    Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
    Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WX20120108, a novel IAP antagonist, induces tumor cell autophagy via activating ROS-FOXO pathway.
    Ding R; Wang X; Chen W; Li Z; Wei AL; Wang QB; Nie AH; Wang LL
    Acta Pharmacol Sin; 2019 Nov; 40(11):1466-1479. PubMed ID: 31316176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
    Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Ohoka N; Okuhira K; Ito M; Nagai K; Shibata N; Hattori T; Ujikawa O; Shimokawa K; Sano O; Koyama R; Fujita H; Teratani M; Matsumoto H; Imaeda Y; Nara H; Cho N; Naito M
    J Biol Chem; 2017 Mar; 292(11):4556-4570. PubMed ID: 28154167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective small-molecule inhibitors of cIAP1/2 proteins reveal that the binding of Smac mimetics to XIAP BIR3 is not required for their effective induction of cell death in tumor cells.
    Sun H; Lu J; Liu L; Yang CY; Wang S
    ACS Chem Biol; 2014 Apr; 9(4):994-1002. PubMed ID: 24521431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain.
    Kester RF; Donnell AF; Lou Y; Remiszewski SW; Lombardo LJ; Chen S; Le NT; Lo J; Moliterni JA; Han X; Hogg JH; Liang W; Michoud C; Rupert KC; Mischke S; Le K; Weisel M; Janson CA; Lukacs CM; Fretland AJ; Hong K; Polonskaia A; Gao L; Li S; Solis DS; Aguilar D; Tardell C; Dvorozniak M; Tannu S; Lee EC; Schutt AD; Goggin B
    J Med Chem; 2013 Oct; 56(20):7788-803. PubMed ID: 24093940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation.
    Ohoka N; Morita Y; Nagai K; Shimokawa K; Ujikawa O; Fujimori I; Ito M; Hayase Y; Okuhira K; Shibata N; Hattori T; Sameshima T; Sano O; Koyama R; Imaeda Y; Nara H; Cho N; Naito M
    J Biol Chem; 2018 May; 293(18):6776-6790. PubMed ID: 29545311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP).
    Tamanini E; Buck IM; Chessari G; Chiarparin E; Day JEH; Frederickson M; Griffiths-Jones CM; Hearn K; Heightman TD; Iqbal A; Johnson CN; Lewis EJ; Martins V; Peakman T; Reader M; Rich SJ; Ward GA; Williams PA; Wilsher NE
    J Med Chem; 2017 Jun; 60(11):4611-4625. PubMed ID: 28492317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARTS binds to a distinct domain in XIAP-BIR3 and promotes apoptosis by a mechanism that is different from other IAP-antagonists.
    Bornstein B; Gottfried Y; Edison N; Shekhtman A; Lev T; Glaser F; Larisch S
    Apoptosis; 2011 Sep; 16(9):869-81. PubMed ID: 21695558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
    Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
    FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotective effects of IAPs revealed by a small molecule antagonist.
    Galbán S; Hwang C; Rumble JM; Oetjen KA; Wright CW; Boudreault A; Durkin J; Gillard JW; Jaquith JB; Morris SJ; Duckett CS
    Biochem J; 2009 Feb; 417(3):765-71. PubMed ID: 18851715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Degradation Mechanisms of Inhibitor of Apoptosis Proteins (IAPs) by the Specific and Nongenetic IAP-Dependent Protein Eraser (SNIPER).
    Ohoka N; Ujikawa O; Shimokawa K; Sameshima T; Shibata N; Hattori T; Nara H; Cho N; Naito M
    Chem Pharm Bull (Tokyo); 2019 Mar; 67(3):203-209. PubMed ID: 30369550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.